Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate-Reference-Cited by-同舟云学术

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate

Published:2023-02-27 Issue:2 Volume:15 Page:123-128
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:
Short-container-title:World J Hepatol

Author:

Fouad Yasser

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference37 articles.

1. Gladstonemay R. WHO urges more care in naming diseases. New York, NY: New York Times. [Internet] [accessed 8 May 2015]. Available from: https://www.seattletimes.com/nation-world/who-urges-more-care-in-naming-diseases/

2. What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’

3. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438

4. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

5. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies;Frontiers in Medicine;2024-01-23

2. What the New Definition of MASLD Left Behind: Dual Etiology With Viral Hepatitis;Clinical Gastroenterology and Hepatology;2023-11

3. Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool;American Journal of Roentgenology;2023-07-19

4. Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage;International Journal of Molecular Sciences;2023-06-29

5. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target;Open Life Sciences;2023-01-01